MedTrace Logo

Trial Comparing Three Single Dose Injections for Knee Osteoarthritis

NCT05492851 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2023-04-10

No results posted yet for this study

Summary

This study is a 3-arm, double-blind, randomized trial comparing the clinical outcomes of Zilretta, Synvisc One, and Monovisc for knee OA.

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

Zilretta

Intra-articular injection to treat knee osteoarthritis

DRUG

Synvisc-One 48 MG in 6 ML Prefilled Syringe

Intra-articular injection to treat knee osteoarthritis

DRUG

Monovisc 88 MG Per 4 ML Prefilled Syringe

Intra-articular injection to treat knee osteoarthritis

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Michael Baria · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-02
Primary Completion
2023-01-11
Completion
2023-01-11
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05492851 on ClinicalTrials.gov